08/17/2023 Research : covid19 and mRNA injections

Posted by Daisy Lear on

 

 

There are two goals of sharing this research, one is to provide information and answers for people experiencing post-sequelae covid19 and vaccine injuries.  The second goal is to provide the informed consent people have not been receiving prior to making choices about the mRNA covid19 injections.

 

 

This research was published in the National Library of Medicine / NIH August 17 and is important to share :  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452662/

 

I view it as my responsibility as a healthcare provider to make sure people are receiving quality information so that individuals are able to make informed choices regarding their health and healthcare.

 

If you are not used to reading research, please find the patience and time to at least read the introduction, scroll through and examine the 12 slides, and conclusion.

 

 

The recording of the live hearing regarding DNA fragments found in covid19 injections was posted on YouTube and later removed.  Instead, here are the associated 2023 research papers :

 

https://www.researchgate.net/publication/369967228_Sequencing_of_bivalent_Moderna_and_Pfizer_mRNA_vaccines_reveals_nanogram_to_microgram_quantities_of_expression_vector_dsDNA_per_dose

 

https://www.researchgate.net/publication/374870815_Speicher_DJ_et_al_DNA_fragments_detected_in_COVID-19_vaccines_in_Canada_DNA_fragments_detected_in_monovalent_and_bivalent

Conclusion from the above link :

Conclusion: These data demonstrate the presence of billions to hundreds of billions of DNA molecules per dose in these vaccines. Using fluorometry, all vaccines exceed the guidelines for residual DNA set by FDA and WHO of 10 ng/dose by 188 – 509-fold. However, qPCR residual DNA content in all vaccines were below these guidelines emphasizing the importance of methodological clarity and consistency when interpreting quantitative guidelines. The preliminary evidence of a dose-response effect of residual DNA measured with qPCR and SAEs warrant confirmation and further investigation. Our findings extend existing concerns about vaccine safety and call into question the relevance of guidelines conceived before the introduction of efficient transfection using LNPs. With several obvious limitations, we urge that our work is replicated under forensic conditions and that guidelines be revised to account for highly efficient DNA transfection and cumulative dosing.

 

https://www.researchgate.net/publication/375065939_DNA_fragments_detected_in_monovalent_and_bivalent_PfizerBioNTech_and_Moderna_modRNA_COVID-19_vaccines_from_Ontario_Canada_Exploratory_dose_response_relationship_with_serious_adverse_events?_sg=ru4HkO-ZKF77-_3ydRol9n68Asg7gKHpJPcIbWvUjgFBDXg9KLVICj6ysIXRhREO94Cw6p7CjXgNHgI&_tp=eyJjb250ZXh0Ijp7ImZpcnN0UGFnZSI6Il9kaXJlY3QiLCJwYWdlIjoiX2RpcmVjdCJ9fQ

 

Excerpt from the above link :

In an exploratory analysis, we found preliminary evidence of a dose response relationship of the amount of DNA per dose and the frequency of serious adverse events (SAEs). This relationship was different for the Pfizer and Moderna products. Size distribution analysis found mean and maximum DNA fragment lengths of 214 base pairs (bp) and 3.5 kb, respectively. The plasmid DNA is likely inside the LNPs and is protected from nucleases.Conclusion: These data demonstrate the presence of billions to hundreds of billions of DNA molecules per dose in these vaccines. Using fluorometry, all vaccines exceed the guidelines for residual DNA set by FDA and WHO of 10 ng/dose by 188 – 509-fold.

 

Preprint December 2023 :

https://www.researchgate.net/publication/376265782_Ribosomal_frameshifting_and_misreading_of_mRNA_in_COVID-19_vaccines_produces_off-target_proteins_and_immune_responses_eliciting_safety_concerns_Comment_on_UK_study_by_Mulroney_et_al

Concluding excerpt from the above link :
The finding that unintended proteins may be produced as a result of vaccination is sufficient cause for regulators to conduct full risk assessments of past or future harms that may have ensued. We note that regulators have previously failed to insist on the study and assessment of risk of the pharmacology and toxicology of novel spike protein heterotrimers forming after injection of the bivalent COVID-19 modRNA vaccines.
The paper was received by Nature on January 25, 2023, accepted for publication on October 31, 2023 and published today, December 6, 2023. This time frame appears rather protracted given the significance of these findings. The study was funded and conducted by agencies of the United Kingdom. The evidence for the formation of off target proteins must surely be considered a reportable adverse event.
We must assume UK regulators and international regulatory agencies including FDA, were apprised of the data many months ago. We await their account of what steps they have taken to investigate why the formation of off-target proteins was not discovered sooner, what toxic  effects they may have caused and what steps they are taken to prevent harm in the future and to inform the public of these findings.